Physician

Jorge H Flores, M.D.

According to 2025 Medicare claims, Jorge Flores, M.D. (NPI: 1356380885) practices nephrology in the Brownsville-Harlingen, TX market, with the plurality of this provider's patient population coming from Cameron, TX. This provider's primary affiliated billing organization is BRAJESH BHATLA MD PA (NPI: 1821044108; TIN: 201195084) and primary practice location at 78550-9290.

Flores' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 349 traditional Medicare patients, billed 2,340 HCPCS/CPT codes, and received $256,359 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 1,735 prescription claims across 262 beneficiaries totaling $621,072 in drug costs, led by Velphoro (Sucroferric Oxyhydroxide). DME data shows 60 claims. Open Payments data shows 44 records totaling $787. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $563,912 to $256,359. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $9,312 to $2,492.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	748	7,200	$563,912
2016	775	6,917	$561,706
2017	779	7,375	$599,000
2018	781	6,523	$585,042
2019	754	6,180	$590,165
2020	743	6,115	$603,690
2021	607	4,670	$494,751
2022	483	3,322	$362,028
2023	404	2,576	$285,481
2024	349	2,340	$256,359

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	373	4,261	$720,999
2016	363	4,216	$918,718
2017	354	3,517	$844,647
2018	319	2,479	$535,435
2019	287	2,302	$466,670
2020	303	2,107	$538,414
2021	297	2,108	$652,891
2022	271	1,992	$692,798
2023	267	1,852	$726,405
2024	262	1,735	$621,072

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	36	278	$11,862
2016	39	288	$15,489
2017	13	246	$7,687
2018	N/R	262	$9,468
2019	N/R	272	$7,826
2020	N/R	289	$9,776
2021	N/R	212	$6,177
2022	N/R	173	$17,265
2023	N/R	89	$4,172
2024	N/R	60	$1,262

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	59	403	$280
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	119	140	$105
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	104	221	$95
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	197	1,022	$64
90935	Hemodialysis procedure with physician evaluation	68	316	$57

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Velphoro	Sucroferric Oxyhydroxide	144	4,503	$328,967
Auryxia	Ferric Citrate	39	1,779	$93,630
Sevelamer Carbonate	Sevelamer Carbonate	146	9,922	$50,004
Lokelma	Sodium Zirconium Cyclosilicate	29	1,581	$27,691
Veltassa	Patiromer Calcium Sorbitex	17	690	$22,476

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	12	$548
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	18	$320
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	18	$244
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	12	$150

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	44	$787	Bayer Healthcare Pharmaceuticals Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jorge H. Flores, M.D.?

Tedicare shows public-source Medicare data for Jorge H. Flores, M.D. (NPI 1356380885), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jorge H. Flores, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jorge H. Flores, M.D.?

Jorge H. Flores, M.D. is linked to BRAJESH BHATLA MD PA (billing NPI 1821044108) in the available physician profile data.

Does Jorge H. Flores, M.D. have Open Payments data?

Jorge H. Flores, M.D. has 44 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.